Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cellectar Biosciences, Inc. - Common Stock
(NQ:
CLRB
)
2.730
-0.170 (-5.86%)
Streaming Delayed Price
Updated: 2:12 PM EST, Mar 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellectar Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today?
↗
January 08, 2024
Cellectar Biosciences Inc (NASDAQ: CLRB) announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a targeted radiotherapy candidate for the treatment of relapsed/refractory...
Via
Benzinga
Wells Fargo Is Warming Up to Enphase Energy (ENPH) Stock
↗
January 08, 2024
Enphase Energy stock is rising higher on Monday as investors react to a new upgrade and increased price target for ENPH from Wells Fargo.
Via
InvestorPlace
Why Is Spirit AeroSystems (SPR) Stock Down 14% Today?
↗
January 08, 2024
Spirit AeroSystems stock is falling hard on Monday as investors in SPR react to one of the company's flights experiencing a mid-air blowout.
Via
InvestorPlace
Why Is LumiraDx (LMDX) Stock Down 13% Today?
↗
January 08, 2024
LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!
Via
InvestorPlace
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
↗
January 08, 2024
Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
January 08, 2024
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
Via
InvestorPlace
Recap: Cellectar Biosciences Q1 Earnings
↗
May 04, 2023
Via
Benzinga
Recap: Cellectar Biosciences Q3 Earnings
↗
November 03, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 06, 2023
Via
Benzinga
Crude Oil Rises 1%; Verb Technology Shares Spike Higher
↗
September 05, 2023
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling 100 points on Tuesday. The Dow traded down 0.31% to 34,728.66 while the NASDAQ rose 0.11% to 14,047.61. The S&P...
Via
Benzinga
Topics
Stocks
Nasdaq Turns Higher; US Factory Orders Fall 2.1% In July
↗
September 05, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.15% to 34,785.92 while the NASDAQ rose 0.12% to 14,048.20. The S&P 500, also...
Via
Benzinga
Topics
Stocks
Cellectar Biosciences: Q2 Earnings Insights
↗
August 05, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
September 05, 2023
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...
Via
Benzinga
Cellectar Biosciences Inc. (NASDAQ: CLRB) Near Top of Volume Charts in Tuesday Trading
September 05, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
March 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 23, 2022
Via
Benzinga
Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket
↗
August 23, 2022
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.
Via
Benzinga
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
↗
July 25, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
Via
Benzinga
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
↗
July 26, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Via
Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
↗
July 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 21, 2022
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.
Via
Benzinga
Why Is United Airlines Down By Over 6%? Here Are 25 Stocks Moving In Thursday's Pre-Market Session
↗
July 21, 2022
Gainers Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 20, 2022
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
↗
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
Recap: Cellectar Biosciences Q1 Earnings
↗
May 10, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Cellectar Biosciences...
Via
Benzinga
51 Biggest Movers From Thursday
↗
April 18, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 14, 2022
Gainers
Via
Benzinga
Here's Why Cellectar Biosciences Shares Are Rising
↗
March 21, 2022
Cellectar Biosciences Inc (NASDAQ: CLRB) shares are trading higher by 12.1% at $0.61 after the company reported better-than-expected fourth-quarter EPS results. Cellectar Biosciences beat estimated...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
